{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T01:42:50Z","timestamp":1751247770510,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yayasan Solidarity Forever."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12033-023-00749-4","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T17:02:34Z","timestamp":1681923754000},"page":"222-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-7973","authenticated-orcid":false,"given":"Anita","family":"Artarini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tia","family":"Hadianti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-9073","authenticated-orcid":false,"given":"Ernawati Arifin","family":"Giri-Rachman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9938-8663","authenticated-orcid":false,"given":"Marselina Irasonia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intan A.","family":"Safitri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurhamidah A.","family":"Hidayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0597-4317","authenticated-orcid":false,"given":"Debbie S.","family":"Retnoningrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8228-1149","authenticated-orcid":false,"given":"Dessy","family":"Natalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"749_CR1","unstructured":"Statistik, B. P. (2021). 2020 Population Census. Berita Resmi Statistik No. 7\/01\/Th. XXIV. Retrieved April 26, 2022, from https:\/\/www.bps.go.id\/pressrelease\/2021\/01\/21\/1854\/hasil-sensus-penduduk-2020.html"},{"issue":"10269","key":"749_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., & Zuidewind, P. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99\u2013111. https:\/\/doi.org\/10.1016\/S0140-6736(20)32661-1","journal-title":"The Lancet"},{"key":"749_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544","author":"J Sadoff","year":"2021","unstructured":"Sadoff, J., Gray, G., Vandebosch, A., C\u00e1rdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., ENSEMBLE Study Group. (2021). Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. The New England journal of medicine. https:\/\/doi.org\/10.1056\/NEJMoa2101544","journal-title":"The New England journal of medicine"},{"issue":"10321","key":"749_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0140-6736(21)02753-7","volume":"399","author":"SA Halperin","year":"2022","unstructured":"Halperin, S. A., Ye, L., MacKinnon-Cameron, D., Smith, B., Cahn, P. E., Ruiz-Palacios, G. M., Ikram, A., Lanas, F., Lourdes Guerrero, M., Mu\u00f1oz Navarro, S. R., Sued, O., Lioznov, D. A., Dzutseva, V., Parveen, G., Zhu, F., Leppan, L., Langley, J. M., Barreto, L., Gou, J., & Zubkova, T. (2022). Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-cont. The Lancet, 399(10321), 237\u2013248. https:\/\/doi.org\/10.1016\/S0140-6736(21)02753-7","journal-title":"The Lancet"},{"issue":"10275","key":"749_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","volume":"397","author":"DY Logunov","year":"2021","unstructured":"Logunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., Botikov, A. G., Izhaeva, F. M., Popova, O., Ozharovskaya, T. A., Esmagambetov, I. B., Favorskaya, I. A., Zrelkin, D. I., Voronina, D. V., & Gintsburg, A. L. (2021). Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet, 397(10275), 671\u2013681. https:\/\/doi.org\/10.1016\/S0140-6736(21)00234-8","journal-title":"The Lancet"},{"issue":"4","key":"749_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis, N., & Ertl, H. C. J. (2004). Adenoviruses as vaccine vectors. Molecular Therapy, 10(4), 616\u2013629. https:\/\/doi.org\/10.1016\/j.ymthe.2004.07.013","journal-title":"Molecular Therapy"},{"issue":"2","key":"749_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40121-020-00300-x","volume":"9","author":"E Padron-Regalado","year":"2020","unstructured":"Padron-Regalado, E. (2020). Vaccines for SARS-CoV-2: Lessons from other coronavirus strains. Infectious Diseases and Therapy, 9(2), 255\u2013274. https:\/\/doi.org\/10.1007\/s40121-020-00300-x","journal-title":"Infectious Diseases and Therapy"},{"issue":"4","key":"749_CR8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/imm.12462","volume":"145","author":"X Guo","year":"2015","unstructured":"Guo, X., Deng, Y., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., & Tan, W. (2015). Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology, 145(4), 476\u2013484. https:\/\/doi.org\/10.1111\/imm.12462","journal-title":"Immunology"},{"issue":"45","key":"749_CR9","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","volume":"32","author":"E Kim","year":"2014","unstructured":"Kim, E., Okada, K., Kenniston, T., Raj, V. S., AlHajri, M. M., Farag, E. A. B. A., AlHajri, F., Osterhaus, A. D., Haagmans, B. L., & Gambotto, A. (2014). Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB\/c mice. Vaccine, 32(45), 5975\u20135982. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.058","journal-title":"Vaccine"},{"key":"749_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17972-1","author":"S Wu","year":"2020","unstructured":"Wu, S., Zhong, G., Zhang, J., Shuai, L., Zhang, Z., Wen, Z., Wang, B., Zhao, Z., Song, X., Chen, Y., Liu, R., Fu, L., Zhang, J., Guo, Q., Wang, C., Yang, Y., Fang, T., Lv, P., Wang, J., & Chen, W. (2020). A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature Communications. https:\/\/doi.org\/10.1038\/s41467-020-17972-1","journal-title":"Nature Communications"},{"issue":"7830","key":"749_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","volume":"586","author":"NB Mercado","year":"2020","unstructured":"Mercado, N. B., Zahn, R., Wegmann, F., Loos, C., Chandrashekar, A., Yu, J., Liu, J., Liu, J., McMahan, K., McMahan, K., He, X., Martinez, D. R., Rutten, L., Bos, R., van Manen, D., Vellinga, J., Custers, J., Langedijk, J. P., & Barouch, D. H. (2020). Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. Nature, 586(7830), 583\u2013588. https:\/\/doi.org\/10.1038\/s41586-020-2607-z","journal-title":"Nature"},{"issue":"1\u20132","key":"749_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jviromet.2008.08.011","volume":"154","author":"M Luo","year":"2008","unstructured":"Luo, M., Tao, P., Li, J., Zhou, S., Guo, D., & Pan, Z. (2008). Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice. Journal of Virological Methods, 154(1\u20132), 121\u2013127. https:\/\/doi.org\/10.1016\/j.jviromet.2008.08.011","journal-title":"Journal of Virological Methods"},{"issue":"10","key":"749_CR13","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.4161\/hv.26009","volume":"9","author":"A Wallace","year":"2013","unstructured":"Wallace, A., West, K., Rothman, A., Ennis, F. A., Lu, S., & Wang, S. (2013). Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1). Human Vaccines and Immunotherapeutics, 9(10), 2095\u20132102. https:\/\/doi.org\/10.4161\/hv.26009","journal-title":"Human Vaccines and Immunotherapeutics"},{"issue":"3","key":"749_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10616-009-9208-x","volume":"59","author":"K Yamada","year":"2009","unstructured":"Yamada, K., Morishita, N., Katsuda, T., Kubo, S., Gotoh, A., & Yamaji, H. (2009). Adenovirus vector production using low-multiplicity infection of 293 cells. Cytotechnology, 59(3), 153\u2013160. https:\/\/doi.org\/10.1007\/s10616-009-9208-x","journal-title":"Cytotechnology"},{"issue":"15","key":"749_CR15","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1007\/s00253-018-9091-5","volume":"102","author":"K da Chen","year":"2018","unstructured":"da Chen, K., Wu, X. X., Yu, D. S., Ou, H. L., Li, Y. H., Zhou, Y. Q., & Li, L. J. (2018). Process optimization for the rapid production of adenoviral vectors for clinical trials in a disposable bioreactor system. Applied Microbiology and Biotechnology, 102(15), 6469\u20136477. https:\/\/doi.org\/10.1007\/s00253-018-9091-5","journal-title":"Applied Microbiology and Biotechnology"},{"issue":"1","key":"749_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/bit.27945","volume":"119","author":"CCD Joe","year":"2022","unstructured":"Joe, C. C. D., Jiang, J., Linke, T., Li, Y., Fedosyuk, S., Gupta, G., Berg, A., Segireddy, R. R., Mainwaring, D., Mainwaring, D., Cashen, P., Rees, B., Chopra, N., Nestola, P., Humphreys, J., Davies, S., Smith, N., Bruce, S., & Douglas, A. D. (2022). Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs. Biotechnology and bioengineering, 119(1), 48\u201358. https:\/\/doi.org\/10.1002\/bit.27945","journal-title":"Biotechnology and bioengineering"},{"issue":"9","key":"749_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/nejmoa2117608","volume":"386","author":"J Sadoff","year":"2022","unstructured":"Sadoff, J., Gray, G., Vandebosch, A., C\u00e1rdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Van Dromme, I., Spiessens, B., Vingerhoets, J., Custers, J., Scheper, G., Robb, M. L., Treanor, J., Ryser, M. F., Barouch, D. H., Swann, E., & Douoguih, M. (2022). Final analysis of efficacy and safety of single-dose Ad26.COV2.S. New England Journal of Medicine, 386(9), 847\u2013860. https:\/\/doi.org\/10.1056\/nejmoa2117608","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"749_CR18","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1002\/jmv.28032","volume":"94","author":"GF Zhang","year":"2022","unstructured":"Zhang, G. F., Meng, W., Chen, L., Ding, L., Feng, J., Perez, J., Ali, A., Sun, S., Liu, Z., Huang, Y., Guo, H., & Gao, S. J. (2022). Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines. Journal of Medical Virology, 94(12), 5678\u20135690. https:\/\/doi.org\/10.1002\/jmv.28032","journal-title":"Journal of Medical Virology"},{"key":"749_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100535","author":"D Kitchin","year":"2022","unstructured":"Kitchin, D., Richardson, S. I., van der Mescht, M. A., Motlou, T., Mzindle, N., Moyo-Gwete, T., Ayres, F., Manamela, N. P., Spencer, H., Lambson, B., Oosthuysen, B., Kaldine, H., du Pisanie, M., Mennen, M., Skelem, S., Williams, N., Ntusi, N. A. B., Burgers, W. A., & Moore, P. L. (2022). Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern. Cell Reports Medicine. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100535","journal-title":"Cell Reports Medicine"},{"issue":"23","key":"749_CR20","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/nejmc2202061","volume":"386","author":"G Gray","year":"2022","unstructured":"Gray, G., Collie, S., Goga, A., Garrett, N., Champion, J., Seocharan, I., Bamford, L., Moultrie, H., & Bekker, L.-G. (2022). Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa. New England Journal of Medicine, 386(23), 2243\u20132245. https:\/\/doi.org\/10.1056\/nejmc2202061","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"749_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41564-021-01053-0","volume":"7","author":"S Nasreen","year":"2022","unstructured":"Nasreen, S., Chung, H., He, S., Brown, K. A., Gubbay, J. B., Buchan, S. A., Fell, D. B., Austin, P. C., Schwartz, K. L., Sundaram, M. E., Sundaram, M. E., Chen, B., Tadrous, M., Wilson, K., Wilson, S. E., & Kwong, J. C. (2022). Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nature Microbiology, 7(3), 379\u2013385. https:\/\/doi.org\/10.1038\/s41564-021-01053-0","journal-title":"Nature Microbiology"},{"issue":"4","key":"749_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/nejmoa2115481","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N., Tessier, E., Stowe, J., Gower, C., Kirsebom, F., Simmons, R., Gallagher, E., Thelwall, S., Groves, N., Dabrera, G., Myers, R., Campbell, C. N. J., Amirthalingam, G., Edmunds, M., Edmunds, M., Zambon, M., Brown, K., Hopkins, S., & Lopez Bernal, J. (2022). Duration of protection against mild and severe disease by Covid-19 Vaccines. New England Journal of Medicine, 386(4), 340\u2013350. https:\/\/doi.org\/10.1056\/nejmoa2115481","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"749_CR23","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.1038\/s41467-022-35168-7","volume":"13","author":"FCM Kirsebom","year":"2022","unstructured":"Kirsebom, F. C. M., Andrews, N., Sachdeva, R., Stowe, J., Ramsay, M., & Lopez Bernal, J. (2022). Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England. Nature Communications, 13(1), 7688. https:\/\/doi.org\/10.1038\/s41467-022-35168-7","journal-title":"Nature Communications"},{"issue":"9","key":"749_CR24","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1128\/jvi.02696-06","volume":"81","author":"P Abbink","year":"2007","unstructured":"Abbink, P., Lemckert, A. A. C., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A. R., O\u2019Brien, K. L., Carville, A., Mansfield, K. G., Goudsmit, J., Havenga, M. J., & Barouch, D. H. (2007). Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. Journal of Virology, 81(9), 4654\u20134663. https:\/\/doi.org\/10.1128\/jvi.02696-06","journal-title":"Journal of Virology"},{"issue":"July","key":"749_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16756","volume":"5","author":"MDJ Dicks","year":"2015","unstructured":"Dicks, M. D. J., Spencer, A. J., Coughlan, L., Bauza, K., Gilbert, S. C., Hill, A. V. S., & Cottingham, M. G. (2015). Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice. Scientific Reports, 5(July), 1\u201315. https:\/\/doi.org\/10.1038\/srep16756","journal-title":"Scientific Reports"},{"issue":"1","key":"749_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02443-0","volume":"4","author":"T Lambe","year":"2021","unstructured":"Lambe, T., Spencer, A. J., Thomas, K. M., Gooch, K. E., Thomas, S., White, A. D., Humphries, H. E., Wright, D., Belij-Rammerstorfer, S., Thakur, N., Conceicao, C., Watson, R., Alden, L., Allen, L., Aram, M., Bewley, K. R., Brunt, E., Brown, P., & Gilbert, S. C. (2021). ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models. Communications Biology, 4(1), 1\u201312. https:\/\/doi.org\/10.1038\/s42003-021-02443-0","journal-title":"Communications Biology"},{"issue":"June","key":"749_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.697074","volume":"12","author":"M Li","year":"2021","unstructured":"Li, M., Guo, J., Lu, S., Zhou, R., Shi, H., Shi, X., Cheng, L., Liang, Q., Liu, H., Wang, P., Wang, N., Wang, Y., Fu, L., Xing, M., Wang, R., Ju, B., Liu, L., Lau, S. Y., & Zhang, L. (2021). Single-Dose immunization with a chimpanzee adenovirus-based vaccine induces sustained and protective immunity against SARS-CoV-2 infection. Frontiers in Immunology, 12(June), 1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2021.697074","journal-title":"Frontiers in Immunology"},{"key":"749_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01070","author":"L Yan","year":"2020","unstructured":"Yan, L., Zhao, Z., Xue, X., Zheng, W., Xu, T., Liu, L., Tian, L., Wang, X., He, H., & Zheng, X. (2020). A bivalent human adenovirus Type 5 vaccine expressing the rabies virus glycoprotein and canine distemper virus hemagglutinin protein confers protective immunity in mice and foxes. Frontiers in Microbiology. https:\/\/doi.org\/10.3389\/fmicb.2020.01070","journal-title":"Frontiers in Microbiology"},{"issue":"4","key":"749_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40521-019-00236-9","volume":"6","author":"MF Liew","year":"2019","unstructured":"Liew, M. F., Chan, A., & Lim, H. F. (2019). House-dust mite Immunotherapy in asthma: Uncertainties and therapeutic strategies. Current Treatment Options in Allergy, 6(4), 363\u2013376. https:\/\/doi.org\/10.1007\/s40521-019-00236-9","journal-title":"Current Treatment Options in Allergy"},{"issue":"20","key":"749_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"6736","author":"FC Zhu","year":"2020","unstructured":"Zhu, F. C., Li, Y. H., Guan, X. H., Hou, L. H., Wang, W. J., Li, J. X., Wu, S. P., Wang, B. S., Wang, Z., Wang, L., Jia, S. Y., Jiang, H. D., Wang, L., Jiang, T., Hu, Y., Gou, J. B., Xu, S. B., Xu, J. J., Wang, X. W., & Chen, W. (2020). Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: A dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet, 6736(20), 1\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(20)31208-3","journal-title":"The Lancet"},{"issue":"10249","key":"749_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","volume":"396","author":"FC Zhu","year":"2020","unstructured":"Zhu, F. C., Guan, X. H., Li, Y. H., Huang, J. Y., Jiang, T., Hou, L. H., Li, J. X., Li, J. X., Wang, L., Wang, W. J., Wu, S. P., Wang, Z., Wu, X. H., Xu, J. J., Zhang, Z., Jia, S. Y., Wang, B. S., Hu, Y., & Chen, W. (2020). Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: A randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet, 396(10249), 479\u2013488. https:\/\/doi.org\/10.1016\/S0140-6736(20)31605-6","journal-title":"The Lancet"},{"issue":"2","key":"749_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","volume":"27","author":"KJ Ewer","year":"2021","unstructured":"Ewer, K. J., Barrett, J. R., Belij-Rammerstorfer, S., Sharpe, H., Makinson, R., Morter, R., Flaxmanm, A., Wright, D., Bellamy, D., Bittaye, M., Dold, C., Provine, N. M., Aboagye, J., Silk, S. E., Alderson, J., Aley, P. K., Angus, B., Berrie, E., & Stafford, E. (2021). T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial. Nature Medicine, 27(2), 270\u2013278. https:\/\/doi.org\/10.1038\/s41591-020-01194-5","journal-title":"Nature Medicine"},{"key":"749_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090100","author":"S Kanagavelu","year":"2014","unstructured":"Kanagavelu, S., Termini, J. M., Gupta, S., Raffa, F. N., Fuller, K. A., Rivas, Y., Philip, S., Kornbluth, R. S., & Stone, G. W. (2014). HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4\u20131BBL enhance t cell mediated anti-viral immunity. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0090100","journal-title":"PLoS ONE"},{"issue":"10","key":"749_CR34","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1128\/jvi.02616-07","volume":"82","author":"J Liu","year":"2008","unstructured":"Liu, J., Ewald, B. A., Lynch, D. M., Denholtz, M., Abbink, P., Lemckert, A. A. C., Carville, A., Mansfield, K. G., Havenga, M. J., Goudsmit, J., & Barouch, D. H. (2008). Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. Journal of Virology, 82(10), 4844\u20134852. https:\/\/doi.org\/10.1128\/jvi.02616-07","journal-title":"Journal of Virology"},{"key":"749_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030077","author":"CT Lee","year":"2012","unstructured":"Lee, C. T., Zhong, L., Mace, T. A., & Repasky, E. A. (2012). Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0030077","journal-title":"PLoS ONE"},{"issue":"6","key":"749_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.ijo.0802917","volume":"29","author":"P-W So","year":"2005","unstructured":"So, P.-W., Herlihy, A. H., & Bell, J. D. (2005). Adiposity induced by adenovirus 5 inoculation. International Journal of Obesity, 29(6), 603\u2013606. https:\/\/doi.org\/10.1038\/sj.ijo.0802917","journal-title":"International Journal of Obesity"},{"issue":"3","key":"749_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00705-018-04132-6","volume":"164","author":"DA Montes-Galindo","year":"2019","unstructured":"Montes-Galindo, D. A., Espiritu-Mojarro, A. C., Melnikov, V., Moy-L\u00f3pez, N. A., Soriano-Hernandez, A. D., Galvan-Salazar, H. R., Guzman-Mu\u00f1iz, J., Martinez-Fierro, M. L., Martinez-Fierro, M. L., Paz-Michel, B., Zaizar-Fregoso, S. A., Sanchez-Ramirez, C. A., Ramirez-Flores, M., Delgado-Enciso, I., & Delgado-Enciso, I. (2019). Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: A study on hamsters. Archives of Virology, 164(3), 775\u2013786. https:\/\/doi.org\/10.1007\/s00705-018-04132-6","journal-title":"Archives of Virology"},{"issue":"12","key":"749_CR38","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/S1473-3099(11)70274-2","volume":"11","author":"NV Dhurandhar","year":"2011","unstructured":"Dhurandhar, N. V. (2011). A framework for identification of infections that contribute to human obesity. The Lancet Infectious Diseases, 11(12), 963\u2013969. https:\/\/doi.org\/10.1016\/S1473-3099(11)70274-2","journal-title":"The Lancet Infectious Diseases"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00749-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00749-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00749-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T16:18:15Z","timestamp":1706026695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-00749-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00749-4","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of the animal use was obtained from the research ethics committee of Padjadjaran University, Bandung, Indonesia with an ethical approval number: 641\/UN6.KEP\/EC\/2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}